Skip to main content
SpringerLink
Log in

Renal Toxicities in the Peri-HSCT Period

  • Chapter
  • First Online:
Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist

  • 1168 Accesses

Abstract

Renal dysfunction within the first 100 days post-hematopoietic stem cell transplantation (HSCT) is common. Many HSCT patients have some degree of renal dysfunction prior to HSCT, and the degree of this dysfunction impacts the extent of renal dysfunction that can occur during the pre-engraftment and early post-engraftment periods of the HSCT course. Renal dysfunction may be due to renal tubule damage, compromised renal blood flow, and obstruction or irritation of post-renal structures. Renal dysfunction impairs the ability of the kidneys to maintain acid-base and electrolyte balance as well as maintain fluid balance and eliminate waste. The renal complications post-HSCT are discussed in Chap. 22. The most common renal toxicities are related to medications frequently used during the peri-HSCT period. These include calcineurin inhibitors, antifungal agents, antibiotics (particularly aminoglycosides), and antiviral agents. In addition, components of conditioning regimens such as alkylators and irradiation to the bladder can cause significant renal toxicity. An infrequent but very serious renal complication is hemorrhagic cystitis which is the focus of this chapter. The remainder of HSCT-associated renal complications is addressed in Chap. 22.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C, et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant. 2003;32(9):925–31. https://doi.org/10.1038/sj.bmt.1704252.

    Article  CAS  PubMed  Google Scholar 

  2. Ruggeri A, Roth-Guepin G, Battipaglia G, Mamez AC, Malard F, Gomez A, et al. Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients. Transpl Infect Dis. 2015;17(6):822–30. https://doi.org/10.1111/tid.12455.

    Article  CAS  PubMed  Google Scholar 

  3. Uhm J, Hamad N, Michelis FV, Shanavas M, Kuruvilla J, Gupta V, et al. The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD. Bone Marrow Transplant. 2014;49(12):1528–34. https://doi.org/10.1038/bmt.2014.181.

    Article  CAS  PubMed  Google Scholar 

  4. Shakiba E, Yaghobi R, Ramzi M. Prevalence of viral infections and hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Exp Clin Transplant. 2011;9(6):405–12

    PubMed  Google Scholar 

  5. Tirindelli MC, Flammia GP, Bove P, Cerretti R, Cudillo L, De Angelis G, et al. Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(10):1612–7. https://doi.org/10.1016/j.bbmt.2014.06.018.

    Article  CAS  PubMed  Google Scholar 

  6. Riachy E, Krauel L, Rich BS, McEvoy MP, Honeyman JN, Boulad F, et al. Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis. J Urol. 2014;191(1):186–92. https://doi.org/10.1016/j.juro.2013.08.007.

    Article  PubMed  Google Scholar 

  7. Decker DB, Karam JA, Wilcox DT. Pediatric hemorrhagic cystitis. J Pediatr Urol. 2009;5(4):254–64. https://doi.org/10.1016/j.jpurol.2009.02.199.

    Article  PubMed  Google Scholar 

  8. Lunde LE, Dasaraju S, Cao Q, Cohn CS, Reding M, Bejanyan N, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant. 2015;50(11):1432–7. https://doi.org/10.1038/bmt.2015.162.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Haldar S, Dru C, Bhowmick NA. Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol. 2014;2(3):199–208

    PubMed  PubMed Central  Google Scholar 

  10. Hayden RT, Gu Z, Liu W, Lovins R, Kasow K, Woodard P, et al. Risk factors for hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2015;17(2):234–41. https://doi.org/10.1111/tid.12364.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Robinson D, Schulz G, Langley R, Donze K, Winchester K, Rodgers C. Evidence-based practice recommendations for hydration in children and adolescents with cancer receiving intravenous cyclophosphamide. J Pediatr Oncol Nurs. 2014;31(4):191–9. https://doi.org/10.1177/1043454214532024.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gonella S, di Pasquale T, Palese A. Preventive measures for cyclophosphamide-related hemorrhagic cystitis in blood and bone marrow transplantation: an Italian multicenter retrospective study. Clin J Oncol Nurs. 2015;19(1):E8–E14. https://doi.org/10.1188/15.CJON.E8-E14.

    Article  PubMed  Google Scholar 

  13. Stillwell TJ, Benson RC. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer. 1988;61(3):451–7

    Article  CAS  PubMed  Google Scholar 

  14. West NJ. Prevention and treatment of hemorrhagic cystitis. Pharmacotherapy. 1997;17(4):696–706

    CAS  PubMed  Google Scholar 

  15. Lukasewycz SJ, Smith AR, Rambachan A, MacMillan ML, Lewis JM, Shukla AR. Intractable hemorrhagic cystitis after hematopoietic stem cell transplantation—is there a role for early urinary diversion in children? J Urol. 2012;188(1):242–6. https://doi.org/10.1016/j.juro.2012.03.020.

    Article  PubMed  Google Scholar 

  16. Alesawi AM, El-Hakim A, Zorn KC, Saad F. Radiation-induced hemorrhagic cystitis. Curr Opin Support Palliat Care. 2014;8(3):235–40. https://doi.org/10.1097/SPC.0000000000000073.

    Article  PubMed  Google Scholar 

  17. Mougin J, Souday V, Martin F, Azzouzi AR, Bigot P. Evaluation of hyperbaric oxygen therapy in the treatment of radiation-induced hemorrhagic cystitis. Urology. 2016;94:42–6. https://doi.org/10.1016/j.urology.2016.04.015.

    Article  PubMed  Google Scholar 

  18. Mori Y, Miyamoto T, Kato K, Kamezaki K, Kuriyama T, Oku S, et al. Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18(3):458–65. https://doi.org/10.1016/j.bbmt.2011.07.025.

    Article  PubMed  Google Scholar 

  19. Purves JT, Graham ML, Ramakumar S. Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis. Urology. 2005;66(3):641–3. https://doi.org/10.1016/j.urology.2005.03.037.

    Article  PubMed  Google Scholar 

  20. Leung AY, Mak R, Lie AK, Yuen KY, Cheng VC, Liang R, et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant. 2002;29(6):509–13. https://doi.org/10.1038/sj.bmt.1703415.

    Article  CAS  PubMed  Google Scholar 

  21. Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D, et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood. 2005;106(3):1130–2. https://doi.org/10.1182/blood-2004-12-4988.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Arcese W, Picardi A, Santarone S, De Angelis G, Cerretti R, Cudillo L, et al. Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update. Bone Marrow Transplant. 2015;50(Suppl 2):S24–30. https://doi.org/10.1038/bmt.2015.91.

    Article  CAS  PubMed  Google Scholar 

  23. Raiola A, Dominietto A, Varaldo R, Ghiso A, Galaverna F, Bramanti S, et al. Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma. Bone Marrow Transplant. 2014;49(2):190–4. https://doi.org/10.1038/bmt.2013.166.

    Article  CAS  PubMed  Google Scholar 

  24. Bashey A, Solomon SR. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor. Bone Marrow Transplant. 2014;49(8):999–1008. https://doi.org/10.1038/bmt.2014.62.

    Article  CAS  PubMed  Google Scholar 

  25. Johnston D, Schurtz E, Tourville E, Jones T, Boemer A, Giel D. Risk factors associated with severity and outcomes in pediatric patients with hemorrhagic cystitis. J Urol. 2016;195(4 Pt 2):1312–7. https://doi.org/10.1016/j.juro.2015.11.035.

    Article  PubMed  Google Scholar 

  26. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology. 1982;20(3):256–8

    Article  CAS  PubMed  Google Scholar 

  27. Hadjibabaie M, Alimoghaddam K, Shamshiri AR, Iravani M, Bahar B, Mousavi A, et al. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol. 2008;26(1):43–6. https://doi.org/10.1016/j.urolonc.2006.12.015.

    Article  PubMed  Google Scholar 

  28. Heath JA, Mishra S, Mitchell S, Waters KD, Tiedemann K. Estrogen as treatment of hemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation. Bone Marrow Transplant. 2006;37(5):523–6. https://doi.org/10.1038/sj.bmt.1705280.

    Article  CAS  PubMed  Google Scholar 

  29. Linder BJ, Tarrell RF, Boorjian SA. Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes. J Urol. 2014;192(6):1687–92. https://doi.org/10.1016/j.juro.2014.06.030.

    Article  PubMed  Google Scholar 

  30. Savona MR, Newton D, Frame D, Levine JE, Mineishi S, Kaul DR. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant. 2007;39(12):783–7. https://doi.org/10.1038/sj.bmt.1705678.

    Article  CAS  PubMed  Google Scholar 

  31. Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol. 2006;81(7):535–7. https://doi.org/10.1002/ajh.20567.

    Article  PubMed  Google Scholar 

  32. Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V, et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis. 2005;40(1):199–201. https://doi.org/10.1086/426594.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Hematology/Oncology and Stem Cell Transplant, Penn State Health Children’s Hospital and Penn State Cancer Center at Penn State Milton, S. Hershey Medical Center, 500 University Drive, MC H085, Hershey, PA, 17033, USA

    Malika Kapadia MD, Terry Wikle Shapiro RN, MSN, CRNP & Robert Greiner MD

Authors
  1. Malika Kapadia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Terry Wikle Shapiro RN, MSN, CRNP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Greiner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert Greiner MD .

Editor information

Editors and Affiliations

  1. Division of Pediatric Oncology/Hematology, Penn State Health Children’s Hospital and Penn State Cancer Institute at the Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA

    Valerie I. Brown

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Kapadia, M., Wikle Shapiro, T., Greiner, R. (2018). Renal Toxicities in the Peri-HSCT Period. In: Brown, V. (eds) Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Springer, Cham. https://doi.org/10.1007/978-3-319-63146-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63146-2_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63144-8

  • Online ISBN: 978-3-319-63146-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation